159 related articles for article (PubMed ID: 37984228)
21. Strong correlation between cancer progression and anti-transcription intermediary factor 1γ antibodies in dermatomyositis patients.
Ogawa-Momohara M; Muro Y; Mitsuma T; Katayama M; Yanaba K; Nara M; Kakeda M; Kono M; Akiyama M
Clin Exp Rheumatol; 2018; 36(6):990-995. PubMed ID: 29745874
[TBL] [Abstract][Full Text] [Related]
22. Malignancy in dermatomyositis and polymyositis: analysis of 192 patients.
Fang YF; Wu YJ; Kuo CF; Luo SF; Yu KH
Clin Rheumatol; 2016 Aug; 35(8):1977-1984. PubMed ID: 27210465
[TBL] [Abstract][Full Text] [Related]
23. Increased risk of venous thromboembolism in patients with dermatomyositis/polymyositis: a nationwide cohort study.
Chung WS; Lin CL; Sung FC; Lu CC; Kao CH
Thromb Res; 2014 Sep; 134(3):622-6. PubMed ID: 25034321
[TBL] [Abstract][Full Text] [Related]
24. Reappraisal of the incidence, various types and risk factors of malignancies in patients with dermatomyositis and polymyositis in Taiwan.
Hsu JL; Liao MF; Chu CC; Kuo HC; Lyu RK; Chang HS; Chen CM; Wu YR; Chang KH; Weng YC; Chang CW; Chiang HI; Cheng CK; Lee PW; Huang CC; Ro LS
Sci Rep; 2021 Feb; 11(1):4545. PubMed ID: 33633147
[TBL] [Abstract][Full Text] [Related]
25. The increased risk of active tuberculosis disease in patients with dermatomyositis - a nationwide retrospective cohort study.
Wu PH; Lin YT; Yang YH; Lin YC; Lin YC
Sci Rep; 2015 Nov; 5():16303. PubMed ID: 26573418
[TBL] [Abstract][Full Text] [Related]
26. The Prevalence of Dementia among Dermatomyositis and Polymyositis Patients: A Retrospective Cohort Study.
Patt YS; Ben-Shabat N; Fisher L; Amital H; Watad A; Sharif K
Isr Med Assoc J; 2023 Jul; 25(7):479-484. PubMed ID: 37461173
[TBL] [Abstract][Full Text] [Related]
27. Increased Risk of Herpes Zoster Following Dermatomyositis and Polymyositis: A Nationwide Population-Based Cohort Study.
Tsai SY; Lin CL; Wong YC; Yang TY; Kuo CF; Cheng JM; Wang JS; Kao CH
Medicine (Baltimore); 2015 Jul; 94(28):e1138. PubMed ID: 26181551
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis of the association of dermatomyositis and polymyositis with cancer.
Wang J; Guo G; Chen G; Wu B; Lu L; Bao L
Br J Dermatol; 2013 Oct; 169(4):838-47. PubMed ID: 23909921
[TBL] [Abstract][Full Text] [Related]
29. Time-Dependent Analysis of Risk of New-Onset Heart Failure Among Patients With Polymyositis and Dermatomyositis.
Lin CY; Chen HA; Hsu TC; Wu CH; Su YJ; Hsu CY
Arthritis Rheumatol; 2022 Jan; 74(1):140-149. PubMed ID: 34180158
[TBL] [Abstract][Full Text] [Related]
30. Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis.
So MW; Koo BS; Kim YG; Lee CK; Yoo B
J Rheumatol; 2011 Nov; 38(11):2432-5. PubMed ID: 21844145
[TBL] [Abstract][Full Text] [Related]
31. Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients.
Sparsa A; Liozon E; Herrmann F; Ly K; Lebrun V; Soria P; Loustaud-Ratti V; Bouyssou-Gauthier ML; Boulinguez S; Bédane C; Jauberteau MO; Vidal E; Bonnetblanc JM
Arch Dermatol; 2002 Jul; 138(7):885-90. PubMed ID: 12071815
[TBL] [Abstract][Full Text] [Related]
32. Dermatomyositis and ovarian cancer: a report of 7 cases and literature review.
Cherin P; Piette JC; Herson S; Bletry O; Wechsler B; Frances C; Godeau P
J Rheumatol; 1993 Nov; 20(11):1897-9. PubMed ID: 8308775
[TBL] [Abstract][Full Text] [Related]
33. Polymyositis/dermatomyositis readmissions: analysis of the nationwide readmission database.
Idolor O; Edigin E; Hino C; He E; Rao J; Ugoh AC; Onobraigho P; Omoike E; Okpujie V; Ezeafulukwe CJ; Eseaton PO; Manadan A; Downey C
Clin Rheumatol; 2023 Oct; 42(10):2833-2839. PubMed ID: 37407906
[TBL] [Abstract][Full Text] [Related]
34. Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study.
Huang YL; Chen YJ; Lin MW; Wu CY; Liu PC; Chen TJ; Chen YC; Jih JS; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
Br J Dermatol; 2009 Oct; 161(4):854-60. PubMed ID: 19558555
[TBL] [Abstract][Full Text] [Related]
35. Dermatomyositis and malignancy. A multicenter cooperative study.
Bonnetblanc JM; Bernard P; Fayol J
Dermatologica; 1990; 180(4):212-6. PubMed ID: 2192925
[TBL] [Abstract][Full Text] [Related]
36. Malignancy in a retrospective cohort of 17 patients with Dermatomyositis or Polymyositis in southern Tunisia.
Sellami K; Mseddi M; Snoussi M; Gharbi H; Frikha F; Salah RB; Jallouli M; Marzouk S; Masmoudi A; Bahloul Z; Turki H
Rom J Intern Med; 2018 Dec; 56(4):243-249. PubMed ID: 29791319
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 2020.
Sun KY; Fan Y; Wang YX; Zhong YJ; Wang GF
Semin Arthritis Rheum; 2021 Feb; 51(1):175-191. PubMed ID: 33383294
[TBL] [Abstract][Full Text] [Related]
38. Serum uric acid is independently associated with hypertension in patients with polymyositis and dermatomyositis.
Liu M; Zhao Z; Lu K; Luo Q; Zhao T; Wang H
J Clin Hypertens (Greenwich); 2023 Nov; 25(11):1019-1026. PubMed ID: 37814496
[TBL] [Abstract][Full Text] [Related]
39. Cancer risk in dermatomyositis: a systematic review of the literature.
Di Rollo D; Abeni D; Tracanna M; Capo A; Amerio P
G Ital Dermatol Venereol; 2014 Oct; 149(5):525-37. PubMed ID: 24975953
[TBL] [Abstract][Full Text] [Related]
40. Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan.
Chen YJ; Wu CY; Huang YL; Wang CB; Shen JL; Chang YT
Arthritis Res Ther; 2010; 12(2):R70. PubMed ID: 20398365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
